Universal Journal of Pharmaceutical Research https://ujpronline.com/index.php/journal <p>Universal Journal of Pharmaceutical research (UJPR) is a peer-reviewed, bi monthly published open access journal aiming to publish original research papers, scientific commentaries, views and review articles, and editorial commentary in the field of the pharmaceutical sciences. The aim of UJPR is to serve as a means for updating the scientific knowledge of the international audience in the pharmaceutical forum and to promote scientific and pharmaceutical research activities related to pharmaceutical education and research, by promoting social contacts among pharma professional of the world.</p> en-US editor@ujpronline.com (Prof. Kapil Kumar) editor@ujpronline.com (Tech Support) Sun, 15 Sep 2024 03:19:37 +0000 OJS 3.3.0.13 http://blogs.law.harvard.edu/tech/rss 60 Message https://ujpronline.com/index.php/journal/article/view/1146 <p>With great pleasure, we would like to congratulate all of the staff and members of the Universal Journal of Pharmaceutical Research (UJPR) on their accomplishments in the field of scientific publishing. The UJPR's primary objective is to continuously improve in order to fulfill the standards of scientific publishing. In recent years, it has made significant progress in this regard by supporting the publication of high-caliber scientific articles that span a wide range of pharmaceutical and medical studies in many sectors. I anticipate greater success in getting our journal included in prestigious indexes like Scopus.</p> <p>Following this welcome, I will write about the significance of the author's face image presentation in the journal, so that readers and research colleagues throughout the globe can identify her/him. It is well established that facial expressions are required for conscious or unconscious emotional expression. Rejection is indicated by a frown. Generally speaking, a smile indicates happiness. "The fundamental basis of empathy and the ability to interpret a person's reactions and predict the likelihood of subsequent behaviors" is the capacity to read emotions in another person's face. Individual differences in face features and expression are largely attributed to the role that facial muscles play in emotion expression. Psychologists contend that the face has significance inherent in its shape rather than being merely a compilation of traits. This supports the idea that an image is perceived as a whole rather than as a collection of fragments. Additionally, studies show that specific brain regions react favorably to faces. "When viewing pictures of strangers, shy adults showed significantly less activity in the fusiform gyrus than sociable adults." The fusiform face area, located within the fusiform gyrus, is engaged by faces and is activated differentially in shy and sociable persons. Additionally, a different study found that specific brain regions react more strongly to an attractive face: "A widely distributed neural network that includes perceptual, decision-making, and reward circuits is excited by facial beauty."</p> <p>Therefore, the "face" of a system with an internal structure is everything that is visible to the outside world, like a building's facade. A press or public relations representative, for instance, could be referred to as the "face" of the company they work for. An anonymous person is occasionally referred to as "faceless" since "face" is associated with uniqueness and is used figuratively in social contexts to denote reputation or status. For this reason, the UJPR feels that the scientists that published their study shouldn't be faceless/nameless; rather, they should be recognized as successful and famous in world society, and as such, their images ought to be on show.</p> Prof. Hassan Abdulwahab Al-Shamahy Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1146 Sat, 14 Sep 2024 00:00:00 +0000 ANTILEISHMANIAL EFFICACY OF HERACLEUM PERSICUM DESF. EX. FISCH. EXTRACTS AGAINST LEISHMANIA TROPICA PROMASTIGOTES https://ujpronline.com/index.php/journal/article/view/1154 <p><strong>Background:</strong><em> Heracleum persicum</em> known as “suhotu” is widely distributed in Adana, Hakkari Van and used in the production of famous Van herb cheese. The antioxidant, antiinflammatory, antidiabetic, antiepileptic, hepatoprotective, and antifungal properties were previously investigated on <em>H. persicum</em> extracts.</p> <p><strong>Objectives:</strong> The purpose of the present study was to comparatively evaluate the <em>in vitro</em> antileishmanial potential of <em>H</em>. <em>persicum</em> extracts prepared by solvents having different polarities. </p> <p><strong>Methods:</strong> The extracts of aerial parts of <em>H</em>. <em>persicum</em> were obtained by maceration, and <em>in vitro</em> antileishmanial efficacy was assayed on <em>L</em>. <em>tropica</em> promastigotes using CellTiter-Glo<sup>®</sup> Cell Viability assay.</p> <p><strong>Results:</strong> The diethylether extract of <em>H. persicum</em> was found to be the most active extract on <em>L. tropica</em> promastigotes with IC<sub>50</sub> value at 151.6 µg/ml. The n-hexane extract with 160.2 µg/ml IC<sub>50</sub> value exhibited higher antileishmanial activity than methanol, ethylacetate and etanol extracts which had IC<sub>50</sub> values at 229, 343.5, and 4708 µg/ml, respectively</p> <p><strong>Conclusions:</strong> The n-hexane and the diethylether extracts of <em>H</em>. <em>persicum</em> which showed remarkable <em>in vitro</em> antileishmanial activities could constitute a valuable source for leishmanicidal compounds.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/r1-89c2eecebd48b7d73625f6b578a4b2aa.gif" alt="" width="355" height="249" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 24 May 2024; <strong>Reviewed</strong> 11 July 2024; <strong>Accepted</strong> 21 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. Asia Selman Abdullah<a href="https://orcid.org/0000-0002-7384-0313" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></strong>, <span class="affiliation">Pharmacy institute, University of Basrah, Iraq</span>, <em>asia_abdullah65@yahoo.com</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 6.0/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0001-5055-7964" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Ahmad Najib, </strong>Universitas Muslim Indonesia, Makassar, Indonesia, <em>ahmad.najib@umi.ac.id</em></p> <p><strong><sub><a href="https://orcid.org/0000-0002-2683-4746" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. Sangeetha Arullappan</strong>, Universiti Tunku Abdul Rahman, Malaysia, <em>sangeetha@utar.edu.my</em></p> Gamze Ozgun, Husniye Kayalar, Fatih Alaylı, İbrahim Cavus, Fatih Dönmez, Ahmet Ozbilgin Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1154 Sat, 14 Sep 2024 00:00:00 +0000 THE IMPACT OF DRUG COST ON MEDICATION ADHERENCE IN NIGERIA: A PERCEPTION AMONG PHARMACISTS https://ujpronline.com/index.php/journal/article/view/1148 <p><strong>Background: </strong>Given Nigeria's huge economic instability, medication expenses may significantly impact medication adherence, creating a barrier to the treatment of various ailments. The study aimed to assess pharmacists' perceptions about the impact of drug costs on medication adherence in Nigeria.</p> <p><strong>Methods</strong>: The study was cross-sectional among practicing pharmacists across Nigeria. The 25 items semi-structured questionnaire was administered online using simple random sampling with the snowballing technique to recruit the pharmacists for the study. The collected data was coded into Microsoft Excel 2016 and subsequently analyzed using IBM SPSS Statistics for Windows, Version 21.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics were utilized to summarize the data, providing an overview of the demographic characteristics and key findings. Inferential statistics, specifically Pearson’s Chi-square test, were employed where applicable to determine the relationships between variables.</p> <p><strong>Results: </strong>Total 161 pharmacists responded to the survey, giving an 80.5% response rate. The respondent rate was mainly young pharmacists (20–30 years old; 82.6%) and predominantly male (51.6%). Almost all the respondents possess only a bachelor of pharmacy degree (91.9%). Total 90% have practiced for 5 years or less, mostly in community settings (60.9%). Generic substitution has been cited as the most important technique to manage drug costs. Non-adherence due to cost was associated with practice settings, whereas adherence counseling was correlated with gender and setting of practice. All differences were not statistically significant at <em>p</em>&lt;0.05.</p> <p><strong>Conclusions: </strong>Most participants believe that the cost of medication is a major barrier to accessing quality healthcare and drives massive non-adherence among those who can barely afford the medicines. Implementing a comprehensive national strategy to enhance the healthcare system, expand the reach of the national health insurance program, and promote cooperation among healthcare practitioners will result in improved clinical outcomes for patients.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/r2-61fa0c2aa81a4f1e2def9b2946158fdd.gif" alt="" width="355" height="249" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 22 May 2024; <strong>Revised</strong> 11 July 2024; <strong>Accepted</strong> 26 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. A.A. Mgbahurike<sub><a href="https://orcid.org/0000-0002-4355-7250" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub></strong>, University of Port Harcourt, Nigeria, <em>amaka_mgbahurike@yahoo.com</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 5.5/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6958-7012" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" width="24" height="22" /></a></sub>Prof. Hassan A.H. Al-Shamahy</strong>, Sana'a University, Yemen, <em>shmahe@yemen.net.ye</em></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6617-5135" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. George Zhu</strong>, Tehran University of Medical Sciences, Tehran, Iran, <em>sansan4240732@163.com</em></p> Victor Chikaodiri Amaechi, Evaristus Jideofor Ugboma, Onyeka Milicent Asumah, Fadilulahi Ayokunle Usman, Chimaobi Jude Nwiyi, Chiagozie Urom Urom-Ndubuisi, Chibuike Solomon Igwe, Doris Mesomachukwu Obi, John Olusegun Okunade, Deborah Okon Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1148 Sat, 14 Sep 2024 00:00:00 +0000 IN VITRO EFFICACY OF VITEX AGNUS-CASTUS EXTRACTS AGAINST TRICHOMONAS VAGINALIS: A POTENTIAL THERAPEUTIC APPROACH https://ujpronline.com/index.php/journal/article/view/1149 <p><strong>Aim and objectives: </strong><em>Trichomonas vaginalis </em>is the most prevalent nonviral sexually transmitted infection globally. The current treatment, 5-nitroimidazole derivatives has raised concerns as a result of drug reliance, allergies, and drug resistance, driving efforts to identify alternative therapies. The <em>Vitex</em> species recognized for their pharmacological attributes including anti-inflammatory, antibacterial, antifungal, and antimicrobial properties are promising candidates for further investigation. </p> <p><strong>Methods:</strong> In this study, the potential of <em>Vitex agnus-castus</em> extracts against <em>T. vaginalis </em>was explored. The water, ethanol, and 60% aqueous ethanol extracts from both leaves and fruits were examined for their effects on metronidazole (MET)-resistant (TV 50143) and sensitive strains (TV-78). Cytotoxicity was evaluated on L929 mouse fibroblast cells to determine the minimum lethal dose for each extract under aerobic and anaerobic conditions. </p> <p><strong>Results: </strong>Antitrichomonial activity, cytotoxic activity and Selectivity Index (SI) values revealed distinct efficacy profiles. Leaf water extract displayed a balanced selectivity profile, while leaf 60% ethanol extract showed moderate to high selectivity. The fruit 60% ethanol extract exhibited significantly elevated selectivity with SI values of 2 and 1 under aerobic and anaerobic conditions, respectively, for the MET-sensitive reference strain, and 3 and 5, respectively, for the MET-resistant reference strain. </p> <p><strong>Conclusion: </strong>These findings underscore the potential of the fruit 60% ethanol extract as a promising candidate for future drug development. Further investigations into its mechanisms and optimization are warranted to enhance its efficacy against <em>T. vaginalis</em>.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/r3-2484c423f1b4f827457a08c5b2a8a114.gif" alt="" width="353" height="249" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 13 May 2024; <strong>Reviewed</strong> 15 July 2024; <strong>Accepted</strong> 21 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: </strong><strong>Dr. Amany Mohamed Alboghdadly<sub><a href="https://orcid.org/0000-0001-6858-7723" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub></strong>, Ibn Sina National College for Medical Studies in Jeddah, Saudi Arabia, <em>amanyalboghdadly@gmail.com </em></p> <p><strong>Average Peer review marks at initial stage:</strong> 6.0/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.5/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0002-4673-7281" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Prof. Ali Gamal Ahmed Al-kaf</strong>, Sana'a university, Yemen, <em>alialkaf21@gmail.com</em></p> <p><strong><sub><a href="https://orcid.org/0000-0001-5609-7436" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. Marwa A. A. Fayed</strong>, University of Sadat City, Egypt, <em>maafayed@gmail.com</em></p> <p><strong><sub><a href="https://orcid.org/0000-0002-2683-4746" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. Sangeetha Arullappan</strong>, Universiti Tunku Abdul Rahman, Malaysia, <em>sangeetha@utar.edu.my</em></p> Ahmet Özbilgin, İbrahim Çavuş, Varol Tunalı, Yener Özel, Çağla Yıldız Alagöz, Hüsniye Kayalar Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1149 Sat, 14 Sep 2024 00:00:00 +0000 HEPATITIS C VIRUS AND LEUKEMIA PATIENTS: PREVALENCE AND RISK FACTORS ASSOCIATED WITH INFECTION AMONG LEUKEMIA PATIENTS WHO ACHIEVE LONG-TERM REMISSION AFTER CHEMOTHERAPY https://ujpronline.com/index.php/journal/article/view/1150 <p><strong>Aim and objective</strong>: Leukemia patients are at elevated risk of hepatitis C virus infections, with anti-HCV prevalence ranging from 4.3% to 70% post-chemotherapy remission. Long-term leukemia survivors' natural histories are unclear. We measured anti-HCV antibodies to investigate the frequency of HCV infections and the associated odds factors of contracting HCV among leukemia patients who achieved long-term remissions after chemotherapy. </p> <p><strong>Methods: </strong>This study is a cross-sectional study, comprising leukemia patients at the oncology center at Kuwait Hospital in Sana'a, Yemen. It included people with leukemia of different ages and genders. Data was collected through a standard questionnaire prepared for this study, which includes clinical symptoms, risk factors, demographic data, and the results of diagnostic tests. Antibody tests for the hepatitis C virus (HCV) were done by ELISA.</p> <p><strong>Results:</strong> The majority of patients with HCV are male, with a mean age of 12.8 years. The prevalence is 5.5%, with males having a higher prevalence. Most patients receive blood transfusions more than twice, with major blood banks, Al-Kuwait hospitals, and private hospitals being the primary sources. AML and ALL are the two most common leukemias. Male patients have a higher risk, and those over 15 years old have a higher risk.</p> <p><strong>Conclusions</strong>: This study is the first in Yemen to investigate the prevalence of HCV infections in patients with leukemia. According to our research, leukemia patients had a greater prevalence of HCV than the general population's national prevalence. However, health care workers (HCWs) and patients receiving maintenance hemodialysis (HD) patients have prevalence's of HCV that are comparable.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/r4-b8f2f53b1466bc6df206e6dfa41dea0e.gif" alt="" width="353" height="252" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 14 May 2024; <strong>Reviewed</strong> 13 July 2024; <strong>Accepted</strong> 22 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. DANIYAN Oluwatoyin Michael<sub><em><a href="https://orcid.org/0000-0003-3669-3542" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></em></sub></strong>, Obafemi Awolowo University, ILE-IFE, Nigeria,<em> toyinpharm@gmail.com</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 6.0/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0003-0174-8742" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. Tamer Elhabibi</strong>, Suez Canal University, Egypt, <em>tamer_hassan@pharm.suez.edu.eg</em></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6617-5135" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. George Zhu</strong>, Tehran University of Medical Sciences, Tehran, Iran, <em>sansan4240732@163.com</em></p> Monya Abdullah Yahya El-Zine, Yusra Ahmed Saleh Dawood, Maged Ali Amer Ali, Khaled Abdulkarim Al-Moyed, Eshrak Adulmalik Al-gunaid, Hassan Abdulwahab Al-Shamahy, Ahmed Mohammed Al-Haddad, Azhar Azher Mohammed Al-Ankoshy Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1150 Sat, 14 Sep 2024 00:00:00 +0000 THE EFFECT OF TEMPERATURE VARIATIONS ON THE DEACETYLATION PROCESS OF CHITOSAN CHARACTERISTICS FROM MUD CRAB (SCYLLA SERRATA) SHELL WASTE https://ujpronline.com/index.php/journal/article/view/1151 <p><strong>Aim and objective: </strong>The aim of this study was to determine the yield value, moisturization, ash, and degree of deacetylation by the variations in deacetylation temperature effect on the quality of chitosan.</p> <p><strong>Methods: </strong>In the synthesis process of chitosan, the first step was demineralization, followed by deproteinization. Afterward, the deacetylation process synthesized the material with temperature variations of 80, 100, and 120ºC. Furthermore, it was characterized by moisture, ash content, and degree of deacetylation. The last step was the Fourier Transform Infra-Red Spectrophotometer (FT-IR) to determine the complete chitosan synthesis.</p> <p><strong>Results:</strong> The results of this study showed that the chitosan yield and water content met the requirements of the quality standards of chitosan. The values obtained were high, which was affected by the temperature. However, the ash content and degree of deacetylation did not meet the requirements of chitosan quality standards. FTIR data showed that the -OH functional group, a -NH group, and no -C=O group from the amide group were found to have characteristics of chitosan formation<strong>. Conclusion:</strong> Mud crab shell waste is a potent raw material for making chitosan. The study also reported that the production of chitosan from mud crab shell waste is affected by temperature.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/r5-30a5e69e3f86ea8bcdd3c1766b475a79.gif" alt="" width="357" height="251" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 19 May 2024; <strong>Reviewed</strong> 24 July 2024; <strong>Accepted</strong> 27 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Prof. Dr. Gorkem Dulger<sub><a href="https://orcid.org/0000-0002-1506-1549" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub></strong>, Duzce University, Turkey,<em> gorkemdulger@yandex.com</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 5.5/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0001-7882-0517" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Prof. Hüsniye Kayalar</strong>, Ege University, Turkey, <em>husniyekayalar@gmail.com</em></p> <p><strong><sub><a href="https://orcid.org/0000-0002-4673-7281" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Prof. Ali Gamal Ahmed Al-kaf</strong>, Sana'a university, Yemen, <em>alialkaf21@gmail.com</em></p> Hasriani, AudiaTriani Olii, Ahmad Najib Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1151 Sat, 14 Sep 2024 00:00:00 +0000 ANTI-INFLAMMATORY EFFECTS OF ROOT BARK METHANOLIC EXTRACT OF BOSWELLIA DALZIELII IN ALBINO MICE https://ujpronline.com/index.php/journal/article/view/1152 <p><strong>Background and objective: </strong><em>Boswellia dalzielii</em> has been traditionally used in the Far North region (Cameroon) to treat fever, rheumatism, asthma and various inflammatory conditions. This investigation was designed to determine the anti-edematous and antioxidant properties to confirm its storied claims.</p> <p><strong>Methods:</strong> The DPPH radical scavenging and reduced Fe<sup>3+</sup>to the Fe<sup>2+</sup> assays were two methods used to evaluate the antioxidant activities. The swelling caused by carrageenan paw and xylene ear edema to cause inflammation were applied to evaluate the anti-inflammatory activities of the extract. The mechanisms of action of the methanol extract were evaluated in the serotonin test. Fever induced by yeast was exploited to value antipyretic activity in albinos animals. Diclofenac, ascorbic acid, and paracetamol were utilized as standard medicaments.</p> <p><strong>Results: </strong>Results published the existence of cardiac glycosides, flavonoid, simple phenols, flavonoids, tannins, coumarins and alkaloids. The results indicated also no acute toxicity and the LD<sub>50</sub> was above 3000 mg/kg. The methanolic extract exhibited the best activity IC<sub>50</sub> (178.12 µg/mL) against DPPH radical with, which was comparable with ascorbic acid (179.12 µg/mL) and a strong reducing power with an IC<sub>50</sub> of about 147.85 µg /mL. In addition, the roots extract of<em> B. dalzielii </em>significantly inhibited (<em>p</em>&lt;0.001) the volume of paw edema, ear edema and the fever.</p> <p><strong>Conclusion</strong>: Finally, the present study published clearly that the<em> B. dalzielii</em> methanolic extract (BDME) possess important antioxidant and anti-edematous effects. The phytoconstituents found in this methanol extract were responsible for the anti-inflammatory and antioxidant effects.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/r6-ac4d815bc0b114d16c24f66f87877ea0.gif" alt="" width="355" height="251" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 21 May 2024; <strong>Reviewed</strong> 15 July 2024; <strong>Accepted</strong> 25 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. Gehan Fawzy Abdel Raoof Kandeel<sub><a href="https://orcid.org/0000-0002-8021-5460" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub></strong>, Pharmacognosy Department, National Research Centre, Dokki, 12622, Giza, Egypt, <em>gehankandeel9@yahoo.com</em> </p> <p><strong>Average Peer review marks at initial stage:</strong> 6.5/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0003-0400-9080" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. Ogbonna B. Onyebuchi</strong>, Nnamdi Azikiwe University, Awka, Nigeria, <em>summitpharm@yahoo.com</em></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6617-5135" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. George Zhu</strong>, Tehran University of Medical Sciences, Tehran, Iran, <em>sansan4240732@163.com</em></p> Jeweldai Vedekoi, Elizé Dadaya, Koubé Juliette, Sokeng Dongmo Sélestin Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1152 Sat, 14 Sep 2024 00:00:00 +0000 ASSESSMENT OF THE ANATOMICAL STRUCTURE OF CANALIS SINUOSUS IN THE ANTERIOR MAXILLA TO AVOID SURGICAL COMPLICATIONS https://ujpronline.com/index.php/journal/article/view/1153 <p><strong>Aims:</strong> The study's objective was to evaluate the canalis sinuosus (CS) anatomical structure in the front maxilla in order to prevent surgical problems in an adult Yemeni population sample acquired using cone-beam computed tomography (CBCT).</p> <p><strong>Materials and Methods: A</strong> retrospective descriptive cross-sectional study was carried out to assess 226 participants' CBCT pictures. 452 sides in total were assessed. There were 140 females (61.9%) and 86 males (38.1%) among the samples. The age distribution was 18–34 years (65%) and over 35 years (35%), with a mean age of 32.13. Version 25 of the Statistical Package of the Social Sciences (SPSS) was used for all statistical analyses.</p> <p><strong>Result: </strong>It was discovered that 160 right (35.4%) and 175 left (38.7%) of the 226 patients and 452 sides had CS. Among these individuals, 117 (51.8%) had unilateral CS and 109 (48.2%) had bilateral CS. The CS was 8.12 mm from the nasal cavity floor (D1), 6.99 mm from the buccal cortical bone ridge (D2), and 13.47 mm from the crest of the alveolar ridge (D3), as the mean distances were measured. Males and females had somewhat higher mean values for the linear measurements D1 and D3, but females had slightly higher mean values for the linear measurement D2. The CS had a mean diameter of 1.11 mm. Left central incisor area was the most commonly observed location of CS, and palataly was the most frequently recorded location of CS.</p> <p><strong>Conclusion: </strong>Since the CS is present in 100% of adult Yemenis, it is imperative that general practitioners and maxillofacial surgeons become more knowledgeable about the position and structure of the CS.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/r7.png" alt="" width="355" height="250" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 19 May 2024; <strong>Reviewed</strong> 12 July 2024; <strong>Accepted</strong> 23 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. Iman Muhammad Higazy<em><a href="https://orcid.org/0000-0002-4200-0418" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></em></strong>, National Research Center, Egypt, <em>imane.higazy@hotmail.com</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 5.5/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0002-1506-1549" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Prof. Gorkem Dulger</strong>, Duzce University, Turkey,<em> gorkemdulger@yandex.com</em></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6617-5135" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. George Zhu</strong>, Tehran University of Medical Sciences, Tehran, Iran, <em>sansan4240732@163.com</em></p> Saleem Taher Ali Ahmed, Sam Abd Alkarem Da'er, Waleed Abdullah Hossin Ahmed Homaid, Hassan Abdulwahab Al-Shamahy, Ahmed Nasser Ali Mabkhout, Basheer Saeed Mohammed Khalid, Azhar Azher Mohammed Al-Ankoshy Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1153 Sat, 14 Sep 2024 00:00:00 +0000 EFFECT OF INTERMAXILLARY FIXATION ON BIOCHEMICAL AND BLOOD MARKERS IN A SAMPLE OF YEMENI ADULTS https://ujpronline.com/index.php/journal/article/view/1147 <p><strong>Background</strong>: Intermaxillary fixation is a technique that is used in the treatment of jaw fractures, orthognathic surgery, temporomandibular joint disorders, and occasionally morbid obesity. However, it disrupts normal nutrition, leading to weakened immunity, impaired healing, and higher complication risks, negatively impacting treatment outcomes and patient recovery. Thus, the aim of this study was to investigate the physiological changes in a sample of Yemeni patients following four weeks of IMF treatment.</p> <p><strong>Materials and Methods</strong>: A study involving ten Yemeni adults underwent intermaxillary fixation for mandibular fractures. Parameters like body weight, lipid profile, liver function tests, kidney function tests, electrolytes, and hemoglobin levels were analyzed before and after treatment at a central blood bank.</p> <p><strong>Results</strong>: The majority of patients were male (80.0%) and aged between 25 and 35 years, and the majority had a unilateral mandibular body fracture (50%). Clinical results after 4 weeks of intermaxillary fixation demonstrated significant reductions in body weight (4.2 kg) and BMI (1.0 kg/m<sup>2</sup>). post-IMF application, lipid profile analysis showed non-significant changes in total cholesterol, high-density lipoprotein levels, low-density lipoprotein, and triglycerides (<em>p</em>&gt;0.05), liver function tests exhibited significant decreases in AST (7.7 µ/l, <em>p</em>=0.044), kidney function tests and electrolyte analysis revealed non-significant changes, and there were significant reductions in T.WBC (2.48 x 10⁹/L) and neutrophils (19.5%) after IMF (<em>p</em>=0.007).</p> <p><strong>Conclusions</strong>: Intermaxillary fixation in Yemeni adults leads to weight loss and changes in liver and blood parameters, indicating its systemic effects. These findings highlight the importance of nutritional support and close monitoring during IMF treatment to mitigate malnutrition risks and optimize healing outcomes.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/r8.png" alt="" width="356" height="247" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 21 May 2024; <strong>Reviewed</strong> 15 July 2024; <strong>Accepted</strong> 25 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. Marwa A. A. Fayed<sub><a href="https://orcid.org/0000-0001-5609-7436" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub></strong>,<strong> </strong>University of Sadat City, Egypt, <em>maafayed@gmail.com</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 6.0/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0002-2168-0469" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Prof. Abdulwahab Ismail Al-kholani</strong>, Dean of Faculty of Dentistry at 21 September University, Yemen. <em>prof_khholani@yahoo.com</em></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6617-5135" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. George Zhu</strong>, Tehran University of Medical Sciences, Tehran, Iran, <em>sansan4240732@163.com</em></p> Waleed Abdullah Hossin Ahmed Homaid, Akram Thabet Nasher, Hassan Abdulwahab Al-Shamahy, Saleem Taher Ali Ahmed, Ahmed Nasser Ali Mabkhout, Basheer Saeed Mohammed Khalid, Azhar Azher Mohammed Al-Ankoshy Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1147 Sat, 14 Sep 2024 00:00:00 +0000 PREVALENCE OF PAROTID TUMORS AMONG YEMENI PATIENTS IN SANA'A CITY, YEMEN https://ujpronline.com/index.php/journal/article/view/1156 <p><strong>Background and aims</strong>: Parotid gland tumors (PGT) are a moderately scarce group of tumors with a broad range of histopathological manifestations and clinical characteristics. To date, most epidemiological studies on salivary gland tumors including PGT are limited in Yemen and this is one of the first studies, so the aim of the study was to determine the prevalence of different tumors affecting the parotid glands and the effect of age and sex on their distribution.</p> <p><strong>Methods</strong>: Epidemiological information as well as demographic data, anatomical site, and histological analysis of PGT were analyzed. The data analyzed included age, sex, site, and histological diagnosis. Data were collected from all histopathological centers covering the majority of Sana'a city between 2019 and 2023.</p> <p><strong>Results</strong>: A total of 284 cases- 69% benign and 31% malignant tumors were examined. Both benign and malignant tumors showed a little male inclination (52.5%) and a peak occurrence between the third and fifth decade. Mucoepidermoid carcinoma (36.4%) and adenoid cystic carcinoma (11.4%) are two common malignant tumor types. Benign parotid tumors include pleomorphic adenoma (71.4%) and Warthin tumors (11.2%) of benigns. Other malignants and benigns are less frequent.</p> <p><strong>Conclusions</strong><strong>: </strong>This study presents the first retrospective study to date to analyze PGT data from health centers spread across Sana'a city. These results should serve the same as the basis for prospect studies assessing the epidemiological geography of these tumors in Sana'a in particular and Yemen in general.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/r9-2d24405eafe76cd3efc8ef197dc0df93.gif" alt="" width="354" height="250" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 18 May 2024; <strong>Reviewed</strong> 12 July 2024; <strong>Accepted</strong> 23 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. </strong><strong>Nuray Arı<sub><a href="https://orcid.org/0000-0002-9259-7427" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub></strong>, Ankara University, Turkiye,<em> ari@ankara.edu.tr</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 6.5/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.5/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0001-5075-9662" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Asmaa Ahmed Mohamed Ahmed Khalifa, </strong>Pharos University, Alexandria, Egypt, <em>asmaa.khalifa@pua.edu.eg</em></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6617-5135" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. George Zhu</strong>, Tehran University of Medical Sciences, Tehran, Iran, <em>sansan4240732@163.com</em></p> Taghreed Ahmed M Al-Kibsi, Heba Gamal Moqbel Ali Al Qirshi, Hassan Abdulwahab Al-Shamahy Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1156 Sat, 14 Sep 2024 00:00:00 +0000 DETERMINATION OF SOME PHARMACOKINETIC PROPERTIES OF ARTEMETHER-LUMEFANTRINE GRANULES IN ALBINO RATS https://ujpronline.com/index.php/journal/article/view/1163 <p><strong>Aim and Objectives</strong>: Malaria is an infectious disease that is caused by plasmodium parasites which is rampant in Sahara Africa and children under 5 years of age are highly vulnerable to this infection by malaria. So the need for the formulation of dosage form for this population using naturally occurring excipients to replace imported ones being currently used by our local manufacturing industries in-order to formulate novel, readily available, affordable and effective antimalarial medicine for children.</p> <p><strong>Methods:</strong> Using the local excipients and its hybrid, the formulated artemether-lumefantrine granules for oral suspension were administered to albino rats, blood samples were collected at predetermined time 0, 1.5, 3, 6, 9, 12, 15, 18, 21, and 24 h respectively and drug contents; artemether-lumefantrine were determined within the stipulated period.</p> <p><strong>Results:</strong> Some pharmacokinetic parameters determined were; maximum concentration, C<sub>max</sub>, time to reach the maximum concentration, T<sub>max</sub>, half-life, t<sub>1/2, </sub>area under the curve, AUC, and mean residence time, MRT, which were for artemether-lumefantrine were 3.9, 3.4, μg/L; 3.2, 6.0 h; 12.5, 14 h; 75.8, 168.5 μg/L.h; 24, 24 h respectively, for the marketed artemether-lumefanthrine granules for oral suspension.4.1, 3.2 μg/L; 1.4, 3.0 h; 3.0, undefined h, 67.0, 65.7 μg/L. h; 18, 18 respectively for hybrid formulated artemether-lumefantrine granules for oral suspension and 3.1, 3.8 μg/L; 2.5, 12.5 h; 4.8, 15 h; 20.2, 281.6 μg/L .h; 18, 18 respectively for the extracted pectin formulated granules.</p> <p><strong>Conclusion: </strong>Optimized formulated artemether-lumefantrine granules were superior to the marketed product in terms of pharmacokinetic values being closer to those of earlier workers.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkkcc/r10.gif" alt="" width="353" height="249" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 13 May 2024; <strong>Reviewed</strong> 16 July 2024; <strong>Accepted</strong> 22 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. Asia Selman Abdullah<a href="https://orcid.org/0000-0002-7384-0313" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></strong>, <span class="affiliation">Pharmacy institute, University of Basrah, Iraq</span>, <em>asia_abdullah65@yahoo.com</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 5.5/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0001-5055-7964" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Ahmad Najib, </strong>Universitas Muslim Indonesia, Makassar, Indonesia, <em>ahmad.najib@umi.ac.id</em></p> <p><strong><sub><a href="https://orcid.org/0000-0002-2683-4746" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. Sangeetha Arullappan</strong>, Universiti Tunku Abdul Rahman, Malaysia, <em>sangeetha@utar.edu.my</em></p> Edwin A. Ubieko, Emmanuel A. Ubieko Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1163 Sat, 14 Sep 2024 00:00:00 +0000 ASSESSMENT OF KNOWLEDGE, ATTITUDES AND PRACTICES ON RHEUMATIC HEART DISEASE AMONG CARDIAC PATIENTS IN AMRAN CITY, YEMEN https://ujpronline.com/index.php/journal/article/view/1155 <p><strong>Background: </strong>All three layers of the heart—the pericardium, myocardium, and endocardium (including the valves)—may sustain irreversible damage as a result of rheumatic heart disease (RHD). Rheumatic heart disease is the result of valvular damage caused by an abnormal immune response to group a streptococcal infection, usually during childhood. The study aims to achieve the assessment of Knowledge, Attitudes and Practices (KAP) on rheumatic heart disease among cardiac patients in Amran city, Yemen.</p> <p><strong>Method:</strong> The descriptive analytical method was used. The questionnaire was used as a tool for collecting data the research sample was (121) of those accompanying rheumatic heart patients in clinics and medical centers in the city of Amran, and they were selected in a simple random method. The data was analyzed and processed statistically using the Statistical Package for the Social Sciences program (SPSS) and many statistical methods, and after conducting the data analysis process and testing the study hypotheses.</p> <p><strong>Result: </strong>The study found that heart patients in Amran have knowledge about rheumatic heart disease causes and symptoms, but lack knowledge about risk factors and disease history. Most suffer from arthritis and do not practice regular exercise. There were no significant differences in opinions about rheumatic heart disease and risk factors among heart patients due to variables like gender, age, education, and living conditions. Rural residents showed statistically significant differences.</p> <p><strong>Conclusions: </strong>The study reveals that patients with rheumatic heart disease have the highest knowledge about the causes and symptoms, but also the risk factors associated with the disease. The knowledge of the disease's history is the most common, followed by rheumatic fever. Arthritis is the most common risk factor. The study found no significant differences in opinions among heart patients in Amran, but significant differences were observed in rural residents' opinions due to factors like gender, age, and living conditions.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/r10-6b4907170fa63e6a376e7aabd7ef6186.gif" alt="" width="355" height="250" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 13 May 2024; <strong>Reviewed</strong> 14 July 2024; <strong>Accepted</strong> 22 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. Sally A. El-Zahaby<sub><a href="https://orcid.org/0000-0002-8751-990X" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub></strong>, Pharos University in Alexandria, Egypt, <em>sally.elzahaby@yahoo.com</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 6.0/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0002-0952-4316" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dina Abd Elfattah Eldakhs, </strong>Pharos university (PUA), Egypt, <em> dina_eldakhs@yahoo.com </em></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6958-7012" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" width="24" height="22" /></a></sub>Prof. Hassan A.H. Al-Shamahy</strong>, Sana'a University, Yemen, <em>shmahe@yemen.net.ye</em></p> Abduallah AA Ali, Reham MA Altholey, Waheed MA Bakri, Yaqup AS Shayea, Mohammed AN Abbas, Abdulnaser SA Aklan, Ziad MA Alseraji Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1155 Sat, 14 Sep 2024 00:00:00 +0000 COMPARATIVE CURE AND SUPPRESSION EFFICACY OF FORMULATED GRANULES WITH A MARKETED SIMILAR PRODUCT https://ujpronline.com/index.php/journal/article/view/1164 <p><strong>Aim and Objectives</strong>: Malaria, a major global health challenge which makes antimalarial drugs one of the commonly prescribed class of drugs World-wide. The most vulnerable are the children and the women especially the expectant mothers. There is need to develop locally and readily available excipients from natural sources to replace imported ones currently being used by our local manufacturing industries. The purpose of the investigation was to test the formulated granules for oral suspension.</p> <p><strong>Methods: </strong>Some weighed albino rats were infected with <em>Plasmodium berghei</em>, then the standard dose of the artemether-lumefantrine oral suspension formulated, a marketed product, and distilled water were administered ; 4/24 mg artemether-lumefantrine per kg body weight per oral to weighed albino rats. Then, other groups were administered standard dose of different formulated granules, a marketed similar product and distilled water respectively. These treated albino rats were then infected with <em>Plasmodium berghei</em> and blood samples were withdrawn from the tail veins, stained with Giemsa stain and the <em>Plasmodium berghei </em>count for the untreated and treated albino rats were determined.</p> <p><strong>Results: </strong>The percentage clearance and suppression were calculated for the different formulations; pectin and its hybrid formulations, a marketed product and distilled water as a control which were 83.73, 85.2, 74.9 and 2.62, and 83.74, 85.2, 74.22, and 0% for curative and suppressive efficacies respectively.</p> <p><strong>Conclusions: </strong>The investigations revealed that the most effective was the hybrid-formulated granules were closely followed by pectin-formulated granules and the least was the marketed product.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkkcc/r12.gif" alt="" width="354" height="250" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 17 May 2024; <strong>Reviewed</strong> 12 July 2024; <strong>Accepted</strong> 20 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. Asia Selman Abdullah<a href="https://orcid.org/0000-0002-7384-0313" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></strong>, <span class="affiliation">Pharmacy institute, University of Basrah, Iraq</span>, <em>asia_abdullah65@yahoo.com</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 6.0/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0001-5055-7964" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Ahmad Najib, </strong>Universitas Muslim Indonesia, Makassar, Indonesia, <em>ahmad.najib@umi.ac.id</em></p> <p><strong><sub><em><a href="https://orcid.org/0000-0003-0970-6109" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></em></sub>Dr. Ahmad Abdelsattar El-Ebiary</strong>, Tanta University Hospitals, Tanta, Egypt, <em>a.ebiary@med.tanta.edu.eg</em></p> Edwin A. Ubieko, Emmanuel A. Ubieko Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1164 Sat, 14 Sep 2024 00:00:00 +0000 THE IMPACT OF COLLABORATIVE CARE ON COST OF TREATMENT FOR THE MANAGEMENT OF HYPERTENSION- A SYSTEMATIC REVIEW https://ujpronline.com/index.php/journal/article/view/1157 <p><strong>Introduction: </strong>For evaluation of the long term costs and benefits of physician-pharmacist collaboration associated with physician management for the treatment of essential hypertension. Around the world the major cause of death is hypertension. It is an incurable condition that requires proper therapeutic regimens for its life-long management. Due to this, hypertension therapy can be financially burdensome to the patient, and the rates of non-compliance are increased.</p> <p><strong>Aims and Objectives: </strong>To observe the results of collaborative, clinical, and interventive approaches to hypertension management, on the cost-effectiveness of therapy, this study aimed to collect and compare cost information on hypertension management, mortality, and morbidity across different countries and cost groups. Using this information, future healthcare expenses can be better planned; for example, by initial emergency response or by changing the way money is distributed. This will lead to more high-pressure jobs. Therefore, it will be more costly to control blood pressure.</p> <p><strong>Method: </strong>A systematic review was conducted using 6 major electronic databases that investigated the influence of collaborative care upon healthcare expenses in hypertensive patients and hypertension therapy costs, before and after the intervention of medical personnel, was observed.</p> <p><strong>Conclusions: </strong>It was concluded that interventions provided by the collaboration of medical personnel, in the management of hypertension, made the therapy more cost-effective and hence the rate of patient compliance and adherence to the therapy were increased.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/rw1.png" alt="" width="354" height="251" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 18 May 2024; <strong>Reviewed</strong> 11 July 2024; <strong>Accepted</strong> 26 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. Tamer Elhabibi<sub><a href="https://orcid.org/0000-0003-0174-8742" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub></strong>, Suez Canal University, Egypt, <em>tamer_hassan@pharm.suez.edu.eg</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 5.5/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0003-0400-9080" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. Ogbonna B. Onyebuchi</strong>, Nnamdi Azikiwe University, Awka, Nigeria, <em>summitpharm@yahoo.com</em></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6617-5135" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. George Zhu</strong>, Tehran University of Medical Sciences, Tehran, Iran, <em>sansan4240732@163.com</em></p> Sara Shahid, Areej Qamar, Umar Ali, Sadaqat Ali, Muhammad Salman Hameed, Syed Muneeb Ashraf, Arooj Nasir, Mahdeem Qamar, Maryam Ayesha, Amna Bajwa, Muhammad Zahid Iqbal Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1157 Sat, 14 Sep 2024 00:00:00 +0000 THE ANTICOAGULATION STRATEGIES FOR MANAGEMENT AND PREVENTION OF STROKE IN NEUROLOGICAL PRACTICE https://ujpronline.com/index.php/journal/article/view/1159 <p>Strokes are categorized as either ischemic or hemorrhagic and the specific interventions will be based on the type of stroke. About 13% of stroke is hemorrhagic and 87% is ischemic. Transient Ischemic Attacks require emergency intervention to decrease the threat of stroke, which is thought to be maximum within the first few days after TIA. Anticoagulants play a major role in the primary and secondary prevention of ischemic strokes.</p> <p>The optimal timing of anticoagulants initiation or resumption inpreventing and managing ischemic strokes is very important. This article will explore certain controversies surrounding this issue, while also highlighting the benefits of antithrombotic therapy used in prevention of ischemic strokes in antiphospholipid antibody syndrome (APS), atrial fibrillation, prosthetic heart valve, cancer, and vascular disorders. Aggressive local and regional efforts to organize stroke care and greater use of evidence-based recommendations may help improve outcomes.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkcc/rw2.png" alt="" width="355" height="250" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 16 May 2024; <strong>Reviewed</strong> 11 July 2024; <strong>Accepted</strong> 24 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Essam Mohamed Eissa<sub><a href="https://orcid.org/0000-0001-8428-6373" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub></strong><strong>, </strong>Beni-Suef University, Egypt, <em>dressamceutics@yahoo.com</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 6.0/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0003-4180-5457" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Taha A.I. El Bassossy</strong>, Medicinal and Aromatic Plants Department, Desert Research Center, Cairo, Egypt, <em>tahachemist2008@gmail.com</em></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6617-5135" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. George Zhu</strong>, Tehran University of Medical Sciences, Tehran, Iran, <em>sansan4240732@163.com</em></p> Mujahed Measar, Ali Alyahawi Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1159 Sat, 14 Sep 2024 00:00:00 +0000 TREATMENT OUTCOMES IN PCOS (POLYCYSTIC OVARIAN SYNDROME)-RELATED INFERTILITY https://ujpronline.com/index.php/journal/article/view/1158 <p>Polycystic ovarian syndrome (PCOS) is one of the underdiagnosed endocrine disorders found to be prevalent among females in the reproductive age group. PCOS effects on an average 8-13% of reproductive aged women, globally. This condition is responsible for causing distress physiologically and psychologically paving the way for a poor quality of life. One of the devastating complications of PCOS is infertility. At present, there is no treatment for PCOS but could be managed by alternate options such as lifestyle modification to <em>in-vitro</em> fertilization. The primary objective of this review article is to analyze the outcomes of certain pharmacological treatment options such as clomiphene citrate which is a selective estrogen receptor modulator, Letrozole an aromatase inhibitor, and gonadotropins for PCOS-related infertility. Clomiphene citrate binds to estrogen receptors indirectly increasing the gonadotropins. Studies confirm a 35-40% successful outcome. Letrozole similarly increases gonadotropins by indirectly decreasing estrogen. A notable increase in the successful outcome was observed with both clomiphene citrate and letrozole, with almost near similar results. The pregnancy outcome was approximately 40% with clomiphene citrate, while letrozole showed 50%. Notably, more side effects were observed in the administration of clomiphene citrate compared to letrozole. Human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (FSHr), that are gonadotropins, were used as they are directly responsible for the maturation of follicles and ovulation itself. The use of gonadotropins increased the pregnancy rate outcome to 20 -30 %, albeit with the risk of multiple births. Furthermore, we have discussed why letrozole and clomiphene citrate are used as the primary therapy compared to gonadotropins.</p> <h5><strong> <img src="https://ujpronline.com/public/site/images/drkkcc/rw3.png" alt="" width="354" height="251" /></strong></h5> <p><strong>Peer Review History: </strong></p> <p><strong>Received</strong> 22 May 2024; <strong>Reviewed</strong> 14 July 2024; <strong>Accepted</strong> 23 August; <strong>Available online</strong> 15 September 2024</p> <p><strong>Academic Editor: Dr. Rola Jadallah<a href="https://orcid.org/0000-0003-1266-5336" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></strong>, Arab American University, Palestine, <em>rola@aauj.edu</em></p> <p><strong>Average Peer review marks at initial stage:</strong> 5.5/10</p> <p><strong>Average Peer review marks at publication stage:</strong> 7.0/10</p> <p><strong>Reviewers:</strong></p> <p><strong><sub><a href="https://orcid.org/0000-0001-6617-5135" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. George Zhu</strong>, Tehran University of Medical Sciences, Tehran, Iran, <em>sansan4240732@163.com</em></p> <p><strong><sub><a href="https://orcid.org/0000-0003-0400-9080" target="_blank" rel="noopener"><img src="https://ujpronline.com/public/site/images/editor/orcid22.jpg" /></a></sub>Dr. Ogbonna B. Onyebuchi</strong>, Nnamdi Azikiwe University, Awka, Nigeria, <em>summitpharm@yahoo.com</em></p> Aminath Efa Ibrahim, Fathimath Ina Shareef, Ahmed Yazdhan, Ahmed Shabin, P. Shaik Syed Ali, Md. Parwez Ahmad Copyright (c) 2024 http://creativecommons.org/licenses/by-nc/4.0 https://ujpronline.com/index.php/journal/article/view/1158 Sat, 14 Sep 2024 00:00:00 +0000